Related Experiment Video
Updated: Apr 24, 2026

Methylated DNA Immunoprecipitation
Published on: January 2, 2009
Early epigenetic cancer decisions
Abstract:
Abstract A cancer dogma states that inactivation of oncogene(s) can cause cancer remission, implying that oncogenes are the Achilles' heel of cancers. This current model of cancer has kept oncogenes firmly in focus as therapeutic targets and is in agreement with the fact that in human cancers all cancerous cells, with independence of the cellular heterogeneity existing within the tumour, carry the same oncogenic genetic lesions. However, recent studies of the interactions between an oncogene and its target cell have shown that oncogenes contribute to cancer development via developmental reprogramming of the epigenome within the target cell. These results provide the first evidence that carcinogenesis can be initiated by epigenetic stem cell reprogramming, and uncover a new role for oncogenes in the origin of cancer. Here we analyse these evidences and discuss how this vision offers new avenues for developing novel anti-cancer interventions.
Insights
Oncogenes, previously thought to drive cancer solely through genetic mutations, may actually initiate cancer by epigenetically reprogramming cells. This discovery opens new avenues for cancer treatment and intervention strategies.
Area of Science:
- Oncology
- Epigenetics
- Cancer Biology
Background:
- The traditional view posits that oncogenes are the primary drivers of cancer, making them key therapeutic targets.
- This model is supported by the observation that most cancer cells share common oncogenic genetic mutations.
Purpose of the Study:
- To analyze recent evidence suggesting oncogenes initiate cancer through epigenetic reprogramming.
- To explore the role of oncogenes in developmental reprogramming of the epigenome.
- To discuss novel anti-cancer intervention strategies based on this new understanding.
Main Methods:
- Review and analysis of existing research on oncogene-target cell interactions.
- Examination of studies linking epigenetic reprogramming to carcinogenesis.
- Discussion of implications for cancer origin and treatment.
Main Results:
- Oncogenes can induce cancer development by epigenetically reprogramming target cells.
- Carcinogenesis may be initiated by epigenetic stem cell reprogramming.
- This highlights a novel role for oncogenes in cancer's origin.
Conclusions:
- The understanding of oncogenes' role in cancer is evolving beyond genetic mutations.
- Epigenetic reprogramming by oncogenes offers new perspectives on cancer development.
- This paradigm shift may lead to innovative therapeutic approaches.
More Related Videos
10:41An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Inheritance of Chromatin Structures
Cancers Originate from Somatic Mutations in a Single Cell